血管外科术后静脉血栓栓塞症的危险因素及化学预防策略启示
单中心回顾性研究纳入1449例大型血管手术,术后90天VTE发生率为3.4%,37%发生于出院后;Caprini评分≥7与出院后VTE相关,化学预防启动延迟>4天与VTE风险增加独立相关,VTE为90天死亡的独立预测因子。
要点
- 大型血管手术后90天VTE发生率为3.4%,其中37%发生于出院后。
- 化学预防启动延迟>4天与VTE风险增加相关(OR 2.4,95%CI 1.1-4.9)。
- Caprini评分≥7与出院后VTE相关,或需考虑出院后化学预防。
核心结论
- 大型血管手术患者VTE风险较高,早期启动化学预防与降低VTE风险相关。
- 出院后VTE发生率可能达到需要出院后化学预防的阈值,尤其Caprini评分≥7者。
研究设计与样本
- 单中心回顾性研究,纳入2013-2020年1449例大型血管手术。
- 手术类型包括EVAR 189例(13%)、TEVAR 169例(12%)、开放主动脉手术318例(22%)、下肢旁路640例(44%)、股动脉内膜剥脱133例(9%)。
主要发现
- 总体VTE发生率为3.4%(65%深静脉血栓,25%肺栓塞,10%两者兼有),37%发生于出院后。
- 症状性VTE发生率为2.4%,EVAR最低(0.0%),开放主动脉手术最高(4.1%;P = .02)。
- VTE患者住院时间更长、终末期肾病和既往VTE比例更高、Caprini评分更高(8 vs 5分;P < .01)。
- VTE患者更可能术后输血≥2U、非计划重返手术室、化学预防/抗凝/抗血小板启动延迟>4天,且90天死亡率增加(P < .01)。
- Caprini评分≥7(29%患者)与出院后VTE相关(2.6% vs 0.7%;P = .01)。
关键数值与推荐
- Caprini评分≥7分见于29%患者,与出院后VTE相关(2.6% vs 0.7%;P = .01)。
- 化学预防、抗凝和抗血小板启动时间>4天与VTE风险增加相关(OR 2.4;95%CI 1.1-4.9)。
临床怎么用
- 对大型血管手术患者应评估VTE风险,尽早启动化学预防。
- Caprini评分≥7的患者可考虑出院后化学预防。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 未报告化学预防的具体方案和剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Venous thromboembolism (VTE) is an important cause of postoperative morbidity and mortality. However, the reported incidence after major vascular surgery has ranged from as low as 1% to >10%. Furthermore, little is known about optimal chemoprophylaxis regimens or rates of postdischarge VTE in this population. In the present study, we aimed to better characterize the rates of in-hospital and postdischarge VTE after major vascular surgery, the role of chemoprophylaxis timing, and the association of VTE with mortality. METHODS: A single-center retrospective study of 1449 major vascular operations (2013-2020) was performed and included 189 endovascular abdominal aortic aneurysm repairs (13%), 169 thoracic endovascular aortic aneurysm repairs (12%), 318 open aortic operations (22%), 640 lower extremity bypasses (44%), and 133 femoral endarterectomies (9%). The baseline characteristics, anticoagulant and antiplatelet medications, and outcomes were abstracted from an electronic database with medical record auditing. Postoperative VTE (pulmonary embolism and deep vein thrombosis) within 90 days of surgery was classified by the location, symptoms, and treatment. A cut point analysis using Youden's index identified the most VTE discriminating timing of chemoprophylaxis (including therapeutic vs prophylactic anticoagulant and antiplatelet medications) and Caprini score. Multivariable logistic regression was used to test the association of VTE with chemoprophylaxis timing, Caprini score, and additional risk factors. Cox proportional hazard modeling was used to measure the association between VTE and mortality. RESULTS: The overall VTE incidence was 3.4% (65% deep vein thrombosis; 25% pulmonary embolism; 10% both), and 37% had occurred after discharge. The rate of symptomatic VTE was 2.4%, which was lowest for endovascular abdominal aortic aneurysm repair (0.0%) and highest for open aortic surgery (4.1%; P = .02). Those who had developed VTE had had a longer length of stay, higher rates of end-stage renal disease and prior VTE, and higher Caprini scores (8 vs 5 points; P < .01 for all). Those who had developed VTE were also more likely to have received ≥2 U of blood postoperatively, required an unplanned return to the operating room, had delayed chemoprophylaxis, anticoagulation, and/or antiplatelet initiation of >4 days postoperatively, and had increased 90-day mortality (P < .01 for all). A Caprini score of ≥7 (29% of patients) was associated with postdischarge VTE (2.6% vs 0.7%; P = .01), and chemoprophylaxis, anticoagulation, and antiplatelet timing of >4 days was associated with an increased adjusted odds of VTE (odds ratio, 2.4; 95% confidence interval, 1.1-4.9). Although no fatal VTEs were identified, VTE was an independent predictor of 90-day mortality (adjusted hazard ratio, 2.7; 95% confidence interval, 1.3-5.9). CONCLUSIONS: These data have shown that patients undergoing major vascular surgery are particularly prone to the development of VTE, with frequent hypercoagulable comorbidities. The earlier initiation of chemoprophylaxis was associated with a reduced risk of VTE development. Furthermore, the postdischarge VTE rates might reach thresholds warranting postdischarge chemoprophylaxis, especially for patients with a Caprini score of ≥7.
引用
- Matthay ZA, Flanagan CP, Sanders K, et al. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34637952. doi:10.1016/j.jvsv.2021.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。